Health and Fitness Health and Fitness
Thu, April 16, 2009
Wed, April 15, 2009
Tue, April 14, 2009
Mon, April 13, 2009
Fri, April 10, 2009
Thu, April 9, 2009
Wed, April 8, 2009
Tue, April 7, 2009
Mon, April 6, 2009
Fri, April 3, 2009
Thu, April 2, 2009
Wed, April 1, 2009
Tue, March 31, 2009
Mon, March 30, 2009
Fri, March 27, 2009
Thu, March 26, 2009
Wed, March 25, 2009
Tue, March 24, 2009
Mon, March 23, 2009
Fri, March 20, 2009
Thu, March 19, 2009
Wed, March 18, 2009
Tue, March 17, 2009
Mon, March 16, 2009
Sun, March 15, 2009
Fri, March 13, 2009
Thu, March 12, 2009
Wed, March 11, 2009
Tue, March 10, 2009
Mon, March 9, 2009
Fri, March 6, 2009
Thu, March 5, 2009
Wed, March 4, 2009
Tue, March 3, 2009
Mon, March 2, 2009
Fri, February 27, 2009
Thu, February 26, 2009
Wed, February 25, 2009
Tue, February 24, 2009
Mon, February 23, 2009

Cypress Bioscience, Inc.: Cypress Bioscience, Inc. to Present at Barclays Capital Global Healthcare Conference


//health-fitness.news-articles.net/content/2009/ .. rclays-capital-global-healthcare-conference.html
Published in Health and Fitness on Monday, March 9th 2009 at 4:34 GMT, Last Modified on 2009-03-09 04:35:16 by Market Wire   Print publication without navigation


SAN DIEGO, CA--(Marketwire - March 9, 2009) - Cypress Bioscience, Inc. (NASDAQ: [ CYPB ]) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Barclays Capital Global Healthcare Conference on March 11, 2009.

The Barclays conference is being held at the Loews Miami Beach Hotel, Miami Beach, FL. Ms. Johnson is scheduled to present on Wednesday, March 11th at 8:30 a.m. Eastern Time. The audio broadcast of this presentation can be accessed at [ http://cc.talkpoint.com/barc002/030909a_rb/?entity=78_P8WPL82 ].

A replay of the presentation will be available at the same web address as well as on Cypress' website, [ http://www.cypressbio.com/events.php ].

About Cypress Bioscience

Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella™ (milnacipran HCl) and the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.

For more information about Cypress, please visit the Company's website at [ www.cypressbio.com ].


Publication Contributing Sources

Similar Health and Fitness Publications